rs565794451
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001126121.2(SLC25A19):c.591C>G(p.Ser197Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S197I) has been classified as Uncertain significance.
Frequency
Consequence
NM_001126121.2 missense
Scores
Clinical Significance
Conservation
Publications
- Amish lethal microcephalyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
 - progressive demyelinating neuropathy with bilateral striatal necrosisInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
 - Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000789  AC: 12AN: 152136Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.0000119  AC: 3AN: 251430 AF XY:  0.00000736   show subpopulations 
GnomAD4 exome  AF:  0.00000958  AC: 14AN: 1461782Hom.:  0  Cov.: 32 AF XY:  0.00000550  AC XY: 4AN XY: 727186 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000788  AC: 12AN: 152254Hom.:  0  Cov.: 31 AF XY:  0.0000403  AC XY: 3AN XY: 74458 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
- -
Inborn genetic diseases    Uncertain:1 
The c.591C>G (p.S197R) alteration is located in exon 6 (coding exon 4) of the SLC25A19 gene. This alteration results from a C to G substitution at nucleotide position 591, causing the serine (S) at amino acid position 197 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided    Uncertain:1 
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 212196). This variant has not been reported in the literature in individuals affected with SLC25A19-related conditions. This variant is present in population databases (rs565794451, gnomAD 0.02%). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 197 of the SLC25A19 protein (p.Ser197Arg). -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at